VKU-78021-99564
5 vaccinations
4 coded responses
49 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 201 / VA
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-10
Registered in v-safe
-
2021-01-10
Dose 1 — Pfizer-BioNTech
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-17
- 2021-01-24
-
2021-01-31
Dose 2 — Pfizer-BioNTech
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-03-02
- 2021-03-07
- 2021-03-14
- 2021-05-04
-
2021-08-01
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Cold symptoms · Healthcare visit (other): Dr visit in personMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-01
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-08-24
Dose 3 — Pfizer-BioNTech
- 2021-09-13
- 2021-09-14
-
2021-09-21
Survey response — day 28, dose 3MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-09-28
- 2021-10-05
- 2021-11-23
- 2022-02-24
-
2022-03-25
Dose 4 — Moderna
-
2022-03-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2022-03-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-03-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2022-03-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness, DiarrheaAdult check-in
- 2022-04-01
- 2022-04-17
- 2022-04-22
- 2022-05-01
- 2022-05-06
-
2022-06-24
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-06-24
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-27
- 2022-06-27
- 2022-09-23
-
2022-09-26
Dose 5 — ModernaCo-administered: Flu
- 2022-10-04
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-12-28
-
2023-03-29
Survey response — 6 months, dose 5MedDRA: Nasopharyngitis, Nephrolithiasis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-29
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-03-30
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-10 | Pfizer-BioNTech | |
| 2 | 2021-01-31 | Pfizer-BioNTech | |
| 3 | 2021-08-24 | Pfizer-BioNTech | No |
| 4 | 2022-03-25 | Moderna | No |
| 5 | 2022-09-26 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-01 | Successful 2021-08-13 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-06-24 | Unsuccessful | |
| 2023-03-29 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Release 9 — day 28, dose 3
Symptoms: Cold symptoms
Release 12 — 3 months, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release